Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

James M Frates

CFO at Amylyx Pharmaceuticals, Inc. (AMLX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $708K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 14SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 9,768234,667 held (−4%) $32.27 $315K -12.8%
Sep 14SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 1,042233,625 held (−0%) $33.23 $35K -15.3%
Mar 4SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 7,909165,638 held (−5%) $14.52 $115K +93.8%
Feb 4SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 3,557173,547 held (−2%) $14.65 $52K +92.1%
Jan 8SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 3,326177,104 held (−2%) $11.11 $37K +153.3%
Oct 2SEC AMLXAmylyx Pharmaceuticals, Inc. Sell 10,558280,430 held (−4%) $14.65 $155K +92.1%